- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2010
- Public Summary Document (PSD) July 2010 PBAC Meeting - PDF
Eculizumab – July 2010
ECULIZUMAB, solution concentrate for I.V. infusion, 300 mg in 30 mL, Soliris®
Last updated
29 October 2010